- The Hong Kong stock market reflects a dual reality where firms either artificially apply AI labels to aging businesses or face the consequences of consumer downgrading.
- While consumer and telecom companies struggle with declining revenues and sluggish growth despite strategic pivots, hard sectors like pharmaceuticals and nuclear energy deliver tangible financial results.
- Companies such as CSPC Pharmaceutical secured FDA approval and milestone payments, and Harbin Electric reported a 61.9% net profit surge in mid-2026.